nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxybutynin—CYP2C8—Vismodegib—skin cancer	0.156	0.241	CbGbCtD
Oxybutynin—CYP3A4—Temozolomide—skin cancer	0.0916	0.141	CbGbCtD
Oxybutynin—CYP3A4—Imiquimod—skin cancer	0.0916	0.141	CbGbCtD
Oxybutynin—CYP2D6—Vemurafenib—skin cancer	0.0789	0.122	CbGbCtD
Oxybutynin—CYP3A4—Vismodegib—skin cancer	0.0635	0.0978	CbGbCtD
Oxybutynin—CYP2C8—Fluorouracil—skin cancer	0.0556	0.0856	CbGbCtD
Oxybutynin—CYP3A4—Vemurafenib—skin cancer	0.0502	0.0773	CbGbCtD
Oxybutynin—CYP3A5—Docetaxel—skin cancer	0.0441	0.068	CbGbCtD
Oxybutynin—CYP3A4—Docetaxel—skin cancer	0.0172	0.0265	CbGbCtD
Oxybutynin—Hexylcaine—SCN10A—skin cancer	0.00524	1	CrCbGaD
Oxybutynin—Menopausal symptoms—Docetaxel—skin cancer	0.000498	0.00144	CcSEcCtD
Oxybutynin—Pain—Imiquimod—skin cancer	0.000496	0.00143	CcSEcCtD
Oxybutynin—Dermatitis bullous—Docetaxel—skin cancer	0.000492	0.00142	CcSEcCtD
Oxybutynin—Stomatitis—Fluorouracil—skin cancer	0.000489	0.00142	CcSEcCtD
Oxybutynin—Urinary tract infection—Fluorouracil—skin cancer	0.000488	0.00141	CcSEcCtD
Oxybutynin—Conjunctivitis—Fluorouracil—skin cancer	0.000488	0.00141	CcSEcCtD
Oxybutynin—Asthenia—Vemurafenib—skin cancer	0.000488	0.00141	CcSEcCtD
Oxybutynin—Hypoaesthesia—Temozolomide—skin cancer	0.000487	0.00141	CcSEcCtD
Oxybutynin—Hallucination—Temozolomide—skin cancer	0.000487	0.00141	CcSEcCtD
Oxybutynin—Pharyngitis—Temozolomide—skin cancer	0.000485	0.0014	CcSEcCtD
Oxybutynin—Urinary tract disorder—Temozolomide—skin cancer	0.000483	0.0014	CcSEcCtD
Oxybutynin—Oedema peripheral—Temozolomide—skin cancer	0.000482	0.00139	CcSEcCtD
Oxybutynin—Pruritus—Vemurafenib—skin cancer	0.000481	0.00139	CcSEcCtD
Oxybutynin—Connective tissue disorder—Temozolomide—skin cancer	0.000481	0.00139	CcSEcCtD
Oxybutynin—Urethral disorder—Temozolomide—skin cancer	0.000479	0.00139	CcSEcCtD
Oxybutynin—Feeling abnormal—Imiquimod—skin cancer	0.000478	0.00138	CcSEcCtD
Oxybutynin—Gastrointestinal pain—Imiquimod—skin cancer	0.000474	0.00137	CcSEcCtD
Oxybutynin—Epistaxis—Fluorouracil—skin cancer	0.000474	0.00137	CcSEcCtD
Oxybutynin—Visual impairment—Temozolomide—skin cancer	0.000471	0.00136	CcSEcCtD
Oxybutynin—Sinusitis—Fluorouracil—skin cancer	0.000471	0.00136	CcSEcCtD
Oxybutynin—Erythema—Dactinomycin—skin cancer	0.000471	0.00136	CcSEcCtD
Oxybutynin—Pain in extremity—Docetaxel—skin cancer	0.00047	0.00136	CcSEcCtD
Oxybutynin—Ill-defined disorder—Bleomycin—skin cancer	0.000468	0.00135	CcSEcCtD
Oxybutynin—Diarrhoea—Vemurafenib—skin cancer	0.000465	0.00135	CcSEcCtD
Oxybutynin—Migraine—Docetaxel—skin cancer	0.000463	0.00134	CcSEcCtD
Oxybutynin—Urticaria—Imiquimod—skin cancer	0.000461	0.00133	CcSEcCtD
Oxybutynin—Abdominal pain—Imiquimod—skin cancer	0.000458	0.00133	CcSEcCtD
Oxybutynin—Eye disorder—Temozolomide—skin cancer	0.000457	0.00132	CcSEcCtD
Oxybutynin—Tinnitus—Temozolomide—skin cancer	0.000456	0.00132	CcSEcCtD
Oxybutynin—Malaise—Bleomycin—skin cancer	0.000455	0.00132	CcSEcCtD
Oxybutynin—Flushing—Temozolomide—skin cancer	0.000454	0.00131	CcSEcCtD
Oxybutynin—Cardiac disorder—Temozolomide—skin cancer	0.000454	0.00131	CcSEcCtD
Oxybutynin—Rhinitis—Fluorouracil—skin cancer	0.000452	0.00131	CcSEcCtD
Oxybutynin—Dizziness—Vemurafenib—skin cancer	0.00045	0.0013	CcSEcCtD
Oxybutynin—Hypoaesthesia—Fluorouracil—skin cancer	0.000448	0.0013	CcSEcCtD
Oxybutynin—Pharyngitis—Fluorouracil—skin cancer	0.000447	0.00129	CcSEcCtD
Oxybutynin—Angiopathy—Temozolomide—skin cancer	0.000444	0.00128	CcSEcCtD
Oxybutynin—Mediastinal disorder—Temozolomide—skin cancer	0.000441	0.00128	CcSEcCtD
Oxybutynin—Cough—Bleomycin—skin cancer	0.00044	0.00127	CcSEcCtD
Oxybutynin—Ill-defined disorder—Dactinomycin—skin cancer	0.000437	0.00126	CcSEcCtD
Oxybutynin—Liver function test abnormal—Docetaxel—skin cancer	0.000434	0.00126	CcSEcCtD
Oxybutynin—Vomiting—Vemurafenib—skin cancer	0.000432	0.00125	CcSEcCtD
Oxybutynin—Dry skin—Docetaxel—skin cancer	0.000431	0.00125	CcSEcCtD
Oxybutynin—Chest pain—Bleomycin—skin cancer	0.00043	0.00124	CcSEcCtD
Oxybutynin—Abdominal pain upper—Docetaxel—skin cancer	0.000429	0.00124	CcSEcCtD
Oxybutynin—Rash—Vemurafenib—skin cancer	0.000429	0.00124	CcSEcCtD
Oxybutynin—Mental disorder—Temozolomide—skin cancer	0.000429	0.00124	CcSEcCtD
Oxybutynin—Dermatitis—Vemurafenib—skin cancer	0.000428	0.00124	CcSEcCtD
Oxybutynin—Hypersensitivity—Imiquimod—skin cancer	0.000427	0.00124	CcSEcCtD
Oxybutynin—Headache—Vemurafenib—skin cancer	0.000426	0.00123	CcSEcCtD
Oxybutynin—Erythema—Temozolomide—skin cancer	0.000426	0.00123	CcSEcCtD
Oxybutynin—Malnutrition—Temozolomide—skin cancer	0.000426	0.00123	CcSEcCtD
Oxybutynin—Breast disorder—Docetaxel—skin cancer	0.000425	0.00123	CcSEcCtD
Oxybutynin—Discomfort—Bleomycin—skin cancer	0.000425	0.00123	CcSEcCtD
Oxybutynin—Malaise—Dactinomycin—skin cancer	0.000425	0.00123	CcSEcCtD
Oxybutynin—Nasopharyngitis—Docetaxel—skin cancer	0.00042	0.00122	CcSEcCtD
Oxybutynin—Dysgeusia—Temozolomide—skin cancer	0.000417	0.00121	CcSEcCtD
Oxybutynin—Asthenia—Imiquimod—skin cancer	0.000416	0.0012	CcSEcCtD
Oxybutynin—Confusional state—Bleomycin—skin cancer	0.000415	0.0012	CcSEcCtD
Oxybutynin—Anaphylactic shock—Bleomycin—skin cancer	0.000412	0.00119	CcSEcCtD
Oxybutynin—Oedema—Bleomycin—skin cancer	0.000412	0.00119	CcSEcCtD
Oxybutynin—Back pain—Temozolomide—skin cancer	0.000412	0.00119	CcSEcCtD
Oxybutynin—Pruritus—Imiquimod—skin cancer	0.00041	0.00119	CcSEcCtD
Oxybutynin—Infection—Bleomycin—skin cancer	0.000409	0.00118	CcSEcCtD
Oxybutynin—Dysphagia—Docetaxel—skin cancer	0.000406	0.00118	CcSEcCtD
Oxybutynin—Nausea—Vemurafenib—skin cancer	0.000404	0.00117	CcSEcCtD
Oxybutynin—Arrhythmia—Fluorouracil—skin cancer	0.000403	0.00116	CcSEcCtD
Oxybutynin—Vision blurred—Temozolomide—skin cancer	0.000401	0.00116	CcSEcCtD
Oxybutynin—Diarrhoea—Imiquimod—skin cancer	0.000397	0.00115	CcSEcCtD
Oxybutynin—Discomfort—Dactinomycin—skin cancer	0.000396	0.00115	CcSEcCtD
Oxybutynin—Ill-defined disorder—Temozolomide—skin cancer	0.000395	0.00114	CcSEcCtD
Oxybutynin—Anorexia—Bleomycin—skin cancer	0.000393	0.00114	CcSEcCtD
Oxybutynin—Erythema—Fluorouracil—skin cancer	0.000392	0.00113	CcSEcCtD
Oxybutynin—Agitation—Temozolomide—skin cancer	0.000391	0.00113	CcSEcCtD
Oxybutynin—Angioedema—Temozolomide—skin cancer	0.000389	0.00113	CcSEcCtD
Oxybutynin—Hypotension—Bleomycin—skin cancer	0.000385	0.00111	CcSEcCtD
Oxybutynin—Oedema—Dactinomycin—skin cancer	0.000384	0.00111	CcSEcCtD
Oxybutynin—Malaise—Temozolomide—skin cancer	0.000384	0.00111	CcSEcCtD
Oxybutynin—Dizziness—Imiquimod—skin cancer	0.000383	0.00111	CcSEcCtD
Oxybutynin—Infection—Dactinomycin—skin cancer	0.000382	0.0011	CcSEcCtD
Oxybutynin—Palpitations—Temozolomide—skin cancer	0.000376	0.00109	CcSEcCtD
Oxybutynin—Musculoskeletal discomfort—Bleomycin—skin cancer	0.000375	0.00109	CcSEcCtD
Oxybutynin—Cough—Temozolomide—skin cancer	0.000372	0.00107	CcSEcCtD
Oxybutynin—Paraesthesia—Bleomycin—skin cancer	0.00037	0.00107	CcSEcCtD
Oxybutynin—Vision blurred—Fluorouracil—skin cancer	0.00037	0.00107	CcSEcCtD
Oxybutynin—Convulsion—Temozolomide—skin cancer	0.000369	0.00107	CcSEcCtD
Oxybutynin—Vomiting—Imiquimod—skin cancer	0.000369	0.00107	CcSEcCtD
Oxybutynin—Hypertension—Temozolomide—skin cancer	0.000368	0.00106	CcSEcCtD
Oxybutynin—Anorexia—Dactinomycin—skin cancer	0.000366	0.00106	CcSEcCtD
Oxybutynin—Rash—Imiquimod—skin cancer	0.000366	0.00106	CcSEcCtD
Oxybutynin—Dermatitis—Imiquimod—skin cancer	0.000365	0.00106	CcSEcCtD
Oxybutynin—Headache—Imiquimod—skin cancer	0.000363	0.00105	CcSEcCtD
Oxybutynin—Arthralgia—Temozolomide—skin cancer	0.000363	0.00105	CcSEcCtD
Oxybutynin—Infestation NOS—Docetaxel—skin cancer	0.000362	0.00105	CcSEcCtD
Oxybutynin—Infestation—Docetaxel—skin cancer	0.000362	0.00105	CcSEcCtD
Oxybutynin—Anxiety—Temozolomide—skin cancer	0.000361	0.00104	CcSEcCtD
Oxybutynin—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—skin cancer	0.00036	0.00104	CcSEcCtD
Oxybutynin—Discomfort—Temozolomide—skin cancer	0.000358	0.00104	CcSEcCtD
Oxybutynin—Decreased appetite—Bleomycin—skin cancer	0.000358	0.00104	CcSEcCtD
Oxybutynin—Dry mouth—Temozolomide—skin cancer	0.000355	0.00103	CcSEcCtD
Oxybutynin—Stomatitis—Docetaxel—skin cancer	0.000353	0.00102	CcSEcCtD
Oxybutynin—Pain—Bleomycin—skin cancer	0.000352	0.00102	CcSEcCtD
Oxybutynin—Conjunctivitis—Docetaxel—skin cancer	0.000352	0.00102	CcSEcCtD
Oxybutynin—Confusional state—Temozolomide—skin cancer	0.00035	0.00101	CcSEcCtD
Oxybutynin—Musculoskeletal discomfort—Dactinomycin—skin cancer	0.00035	0.00101	CcSEcCtD
Oxybutynin—Oedema—Temozolomide—skin cancer	0.000348	0.00101	CcSEcCtD
Oxybutynin—Anaphylactic shock—Temozolomide—skin cancer	0.000348	0.00101	CcSEcCtD
Oxybutynin—Infection—Temozolomide—skin cancer	0.000345	0.000999	CcSEcCtD
Oxybutynin—Nausea—Imiquimod—skin cancer	0.000344	0.000996	CcSEcCtD
Oxybutynin—Epistaxis—Docetaxel—skin cancer	0.000342	0.000989	CcSEcCtD
Oxybutynin—Nervous system disorder—Temozolomide—skin cancer	0.000341	0.000986	CcSEcCtD
Oxybutynin—Convulsion—Fluorouracil—skin cancer	0.00034	0.000983	CcSEcCtD
Oxybutynin—Feeling abnormal—Bleomycin—skin cancer	0.000339	0.000982	CcSEcCtD
Oxybutynin—Skin disorder—Temozolomide—skin cancer	0.000338	0.000976	CcSEcCtD
Oxybutynin—Chest pain—Fluorouracil—skin cancer	0.000334	0.000966	CcSEcCtD
Oxybutynin—Decreased appetite—Dactinomycin—skin cancer	0.000334	0.000966	CcSEcCtD
Oxybutynin—Fatigue—Dactinomycin—skin cancer	0.000331	0.000958	CcSEcCtD
Oxybutynin—Anorexia—Temozolomide—skin cancer	0.000331	0.000958	CcSEcCtD
Oxybutynin—Discomfort—Fluorouracil—skin cancer	0.00033	0.000955	CcSEcCtD
Oxybutynin—Pain—Dactinomycin—skin cancer	0.000329	0.00095	CcSEcCtD
Oxybutynin—Urticaria—Bleomycin—skin cancer	0.000327	0.000947	CcSEcCtD
Oxybutynin—Rhinitis—Docetaxel—skin cancer	0.000326	0.000943	CcSEcCtD
Oxybutynin—Hypoaesthesia—Docetaxel—skin cancer	0.000324	0.000936	CcSEcCtD
Oxybutynin—Confusional state—Fluorouracil—skin cancer	0.000323	0.000934	CcSEcCtD
Oxybutynin—Pharyngitis—Docetaxel—skin cancer	0.000323	0.000934	CcSEcCtD
Oxybutynin—Urinary tract disorder—Docetaxel—skin cancer	0.000321	0.000929	CcSEcCtD
Oxybutynin—Oedema peripheral—Docetaxel—skin cancer	0.00032	0.000927	CcSEcCtD
Oxybutynin—Anaphylactic shock—Fluorouracil—skin cancer	0.00032	0.000926	CcSEcCtD
Oxybutynin—Oedema—Fluorouracil—skin cancer	0.00032	0.000926	CcSEcCtD
Oxybutynin—Connective tissue disorder—Docetaxel—skin cancer	0.00032	0.000925	CcSEcCtD
Oxybutynin—Urethral disorder—Docetaxel—skin cancer	0.000319	0.000922	CcSEcCtD
Oxybutynin—Infection—Fluorouracil—skin cancer	0.000318	0.00092	CcSEcCtD
Oxybutynin—Feeling abnormal—Dactinomycin—skin cancer	0.000317	0.000916	CcSEcCtD
Oxybutynin—Musculoskeletal discomfort—Temozolomide—skin cancer	0.000317	0.000916	CcSEcCtD
Oxybutynin—Insomnia—Temozolomide—skin cancer	0.000314	0.000909	CcSEcCtD
Oxybutynin—Gastrointestinal pain—Dactinomycin—skin cancer	0.000314	0.000909	CcSEcCtD
Oxybutynin—Nervous system disorder—Fluorouracil—skin cancer	0.000314	0.000908	CcSEcCtD
Oxybutynin—Visual impairment—Docetaxel—skin cancer	0.000313	0.000907	CcSEcCtD
Oxybutynin—Tachycardia—Fluorouracil—skin cancer	0.000313	0.000904	CcSEcCtD
Oxybutynin—Paraesthesia—Temozolomide—skin cancer	0.000312	0.000903	CcSEcCtD
Oxybutynin—Somnolence—Temozolomide—skin cancer	0.000309	0.000894	CcSEcCtD
Oxybutynin—Dyspepsia—Temozolomide—skin cancer	0.000306	0.000885	CcSEcCtD
Oxybutynin—Anorexia—Fluorouracil—skin cancer	0.000305	0.000883	CcSEcCtD
Oxybutynin—Eye disorder—Docetaxel—skin cancer	0.000304	0.000879	CcSEcCtD
Oxybutynin—Abdominal pain—Dactinomycin—skin cancer	0.000304	0.000879	CcSEcCtD
Oxybutynin—Hypersensitivity—Bleomycin—skin cancer	0.000304	0.000878	CcSEcCtD
Oxybutynin—Decreased appetite—Temozolomide—skin cancer	0.000302	0.000874	CcSEcCtD
Oxybutynin—Flushing—Docetaxel—skin cancer	0.000302	0.000873	CcSEcCtD
Oxybutynin—Cardiac disorder—Docetaxel—skin cancer	0.000302	0.000873	CcSEcCtD
Oxybutynin—Gastrointestinal disorder—Temozolomide—skin cancer	0.0003	0.000868	CcSEcCtD
Oxybutynin—Fatigue—Temozolomide—skin cancer	0.0003	0.000867	CcSEcCtD
Oxybutynin—Hypotension—Fluorouracil—skin cancer	0.000299	0.000865	CcSEcCtD
Oxybutynin—Constipation—Temozolomide—skin cancer	0.000297	0.00086	CcSEcCtD
Oxybutynin—Pain—Temozolomide—skin cancer	0.000297	0.00086	CcSEcCtD
Oxybutynin—Asthenia—Bleomycin—skin cancer	0.000296	0.000855	CcSEcCtD
Oxybutynin—Angiopathy—Docetaxel—skin cancer	0.000295	0.000854	CcSEcCtD
Oxybutynin—Mediastinal disorder—Docetaxel—skin cancer	0.000293	0.000848	CcSEcCtD
Oxybutynin—Musculoskeletal discomfort—Fluorouracil—skin cancer	0.000292	0.000844	CcSEcCtD
Oxybutynin—Pruritus—Bleomycin—skin cancer	0.000291	0.000843	CcSEcCtD
Oxybutynin—Arrhythmia—Docetaxel—skin cancer	0.000291	0.000841	CcSEcCtD
Oxybutynin—Insomnia—Fluorouracil—skin cancer	0.00029	0.000838	CcSEcCtD
Oxybutynin—Paraesthesia—Fluorouracil—skin cancer	0.000288	0.000832	CcSEcCtD
Oxybutynin—Feeling abnormal—Temozolomide—skin cancer	0.000286	0.000828	CcSEcCtD
Oxybutynin—Mental disorder—Docetaxel—skin cancer	0.000285	0.000824	CcSEcCtD
Oxybutynin—Somnolence—Fluorouracil—skin cancer	0.000285	0.000823	CcSEcCtD
Oxybutynin—Gastrointestinal pain—Temozolomide—skin cancer	0.000284	0.000822	CcSEcCtD
Oxybutynin—Erythema—Docetaxel—skin cancer	0.000283	0.000819	CcSEcCtD
Oxybutynin—Malnutrition—Docetaxel—skin cancer	0.000283	0.000819	CcSEcCtD
Oxybutynin—Hypersensitivity—Dactinomycin—skin cancer	0.000283	0.000819	CcSEcCtD
Oxybutynin—Dyspepsia—Fluorouracil—skin cancer	0.000282	0.000815	CcSEcCtD
Oxybutynin—Decreased appetite—Fluorouracil—skin cancer	0.000278	0.000805	CcSEcCtD
Oxybutynin—Dysgeusia—Docetaxel—skin cancer	0.000277	0.000802	CcSEcCtD
Oxybutynin—Gastrointestinal disorder—Fluorouracil—skin cancer	0.000276	0.0008	CcSEcCtD
Oxybutynin—Urticaria—Temozolomide—skin cancer	0.000276	0.000799	CcSEcCtD
Oxybutynin—Asthenia—Dactinomycin—skin cancer	0.000276	0.000797	CcSEcCtD
Oxybutynin—Abdominal pain—Temozolomide—skin cancer	0.000275	0.000795	CcSEcCtD
Oxybutynin—Back pain—Docetaxel—skin cancer	0.000274	0.000792	CcSEcCtD
Oxybutynin—Pain—Fluorouracil—skin cancer	0.000274	0.000792	CcSEcCtD
Oxybutynin—Feeling abnormal—Fluorouracil—skin cancer	0.000264	0.000763	CcSEcCtD
Oxybutynin—Diarrhoea—Dactinomycin—skin cancer	0.000263	0.00076	CcSEcCtD
Oxybutynin—Vomiting—Bleomycin—skin cancer	0.000262	0.000758	CcSEcCtD
Oxybutynin—Rash—Bleomycin—skin cancer	0.00026	0.000751	CcSEcCtD
Oxybutynin—Dermatitis—Bleomycin—skin cancer	0.00026	0.000751	CcSEcCtD
Oxybutynin—Hypersensitivity—Temozolomide—skin cancer	0.000256	0.000741	CcSEcCtD
Oxybutynin—Urticaria—Fluorouracil—skin cancer	0.000254	0.000736	CcSEcCtD
Oxybutynin—Syncope—Docetaxel—skin cancer	0.000254	0.000734	CcSEcCtD
Oxybutynin—Palpitations—Docetaxel—skin cancer	0.00025	0.000724	CcSEcCtD
Oxybutynin—Asthenia—Temozolomide—skin cancer	0.000249	0.000721	CcSEcCtD
Oxybutynin—Loss of consciousness—Docetaxel—skin cancer	0.000249	0.00072	CcSEcCtD
Oxybutynin—Cough—Docetaxel—skin cancer	0.000247	0.000715	CcSEcCtD
Oxybutynin—Pruritus—Temozolomide—skin cancer	0.000246	0.000711	CcSEcCtD
Oxybutynin—Convulsion—Docetaxel—skin cancer	0.000245	0.00071	CcSEcCtD
Oxybutynin—Nausea—Bleomycin—skin cancer	0.000245	0.000708	CcSEcCtD
Oxybutynin—Hypertension—Docetaxel—skin cancer	0.000244	0.000707	CcSEcCtD
Oxybutynin—Vomiting—Dactinomycin—skin cancer	0.000244	0.000707	CcSEcCtD
Oxybutynin—Rash—Dactinomycin—skin cancer	0.000242	0.000701	CcSEcCtD
Oxybutynin—Arthralgia—Docetaxel—skin cancer	0.000241	0.000697	CcSEcCtD
Oxybutynin—Chest pain—Docetaxel—skin cancer	0.000241	0.000697	CcSEcCtD
Oxybutynin—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—skin cancer	0.000239	0.000692	CcSEcCtD
Oxybutynin—Diarrhoea—Temozolomide—skin cancer	0.000238	0.000688	CcSEcCtD
Oxybutynin—Hypersensitivity—Fluorouracil—skin cancer	0.000236	0.000682	CcSEcCtD
Oxybutynin—Dry mouth—Docetaxel—skin cancer	0.000236	0.000682	CcSEcCtD
Oxybutynin—Confusional state—Docetaxel—skin cancer	0.000233	0.000674	CcSEcCtD
Oxybutynin—Anaphylactic shock—Docetaxel—skin cancer	0.000231	0.000668	CcSEcCtD
Oxybutynin—Oedema—Docetaxel—skin cancer	0.000231	0.000668	CcSEcCtD
Oxybutynin—Dizziness—Temozolomide—skin cancer	0.00023	0.000665	CcSEcCtD
Oxybutynin—Infection—Docetaxel—skin cancer	0.00023	0.000664	CcSEcCtD
Oxybutynin—Nausea—Dactinomycin—skin cancer	0.000228	0.00066	CcSEcCtD
Oxybutynin—Shock—Docetaxel—skin cancer	0.000227	0.000658	CcSEcCtD
Oxybutynin—Nervous system disorder—Docetaxel—skin cancer	0.000227	0.000656	CcSEcCtD
Oxybutynin—Pruritus—Fluorouracil—skin cancer	0.000227	0.000655	CcSEcCtD
Oxybutynin—Tachycardia—Docetaxel—skin cancer	0.000226	0.000652	CcSEcCtD
Oxybutynin—Skin disorder—Docetaxel—skin cancer	0.000224	0.000649	CcSEcCtD
Oxybutynin—Vomiting—Temozolomide—skin cancer	0.000221	0.000639	CcSEcCtD
Oxybutynin—Anorexia—Docetaxel—skin cancer	0.00022	0.000637	CcSEcCtD
Oxybutynin—Rash—Temozolomide—skin cancer	0.000219	0.000634	CcSEcCtD
Oxybutynin—Diarrhoea—Fluorouracil—skin cancer	0.000219	0.000634	CcSEcCtD
Oxybutynin—Dermatitis—Temozolomide—skin cancer	0.000219	0.000633	CcSEcCtD
Oxybutynin—Headache—Temozolomide—skin cancer	0.000218	0.00063	CcSEcCtD
Oxybutynin—Hypotension—Docetaxel—skin cancer	0.000216	0.000625	CcSEcCtD
Oxybutynin—Dizziness—Fluorouracil—skin cancer	0.000212	0.000612	CcSEcCtD
Oxybutynin—Musculoskeletal discomfort—Docetaxel—skin cancer	0.000211	0.000609	CcSEcCtD
Oxybutynin—Insomnia—Docetaxel—skin cancer	0.000209	0.000605	CcSEcCtD
Oxybutynin—Paraesthesia—Docetaxel—skin cancer	0.000208	0.0006	CcSEcCtD
Oxybutynin—Nausea—Temozolomide—skin cancer	0.000206	0.000597	CcSEcCtD
Oxybutynin—Somnolence—Docetaxel—skin cancer	0.000205	0.000594	CcSEcCtD
Oxybutynin—Vomiting—Fluorouracil—skin cancer	0.000204	0.000589	CcSEcCtD
Oxybutynin—Dyspepsia—Docetaxel—skin cancer	0.000203	0.000588	CcSEcCtD
Oxybutynin—Rash—Fluorouracil—skin cancer	0.000202	0.000584	CcSEcCtD
Oxybutynin—Dermatitis—Fluorouracil—skin cancer	0.000202	0.000583	CcSEcCtD
Oxybutynin—Decreased appetite—Docetaxel—skin cancer	0.000201	0.000581	CcSEcCtD
Oxybutynin—Headache—Fluorouracil—skin cancer	0.000201	0.00058	CcSEcCtD
Oxybutynin—Gastrointestinal disorder—Docetaxel—skin cancer	0.0002	0.000577	CcSEcCtD
Oxybutynin—Fatigue—Docetaxel—skin cancer	0.000199	0.000576	CcSEcCtD
Oxybutynin—Constipation—Docetaxel—skin cancer	0.000198	0.000572	CcSEcCtD
Oxybutynin—Pain—Docetaxel—skin cancer	0.000198	0.000572	CcSEcCtD
Oxybutynin—Feeling abnormal—Docetaxel—skin cancer	0.00019	0.000551	CcSEcCtD
Oxybutynin—Nausea—Fluorouracil—skin cancer	0.00019	0.00055	CcSEcCtD
Oxybutynin—Gastrointestinal pain—Docetaxel—skin cancer	0.000189	0.000547	CcSEcCtD
Oxybutynin—Abdominal pain—Docetaxel—skin cancer	0.000183	0.000528	CcSEcCtD
Oxybutynin—Hypersensitivity—Docetaxel—skin cancer	0.00017	0.000492	CcSEcCtD
Oxybutynin—Asthenia—Docetaxel—skin cancer	0.000166	0.00048	CcSEcCtD
Oxybutynin—Pruritus—Docetaxel—skin cancer	0.000164	0.000473	CcSEcCtD
Oxybutynin—Diarrhoea—Docetaxel—skin cancer	0.000158	0.000457	CcSEcCtD
Oxybutynin—Dizziness—Docetaxel—skin cancer	0.000153	0.000442	CcSEcCtD
Oxybutynin—Vomiting—Docetaxel—skin cancer	0.000147	0.000425	CcSEcCtD
Oxybutynin—Rash—Docetaxel—skin cancer	0.000146	0.000421	CcSEcCtD
Oxybutynin—Dermatitis—Docetaxel—skin cancer	0.000146	0.000421	CcSEcCtD
Oxybutynin—Headache—Docetaxel—skin cancer	0.000145	0.000419	CcSEcCtD
Oxybutynin—Nausea—Docetaxel—skin cancer	0.000137	0.000397	CcSEcCtD
